Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Hodgkin Disease × fludarabine × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 60 Expanded_access 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Mantle-Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1

Interventions

fludarabine phosphate 2 plerixafor 1 fludarabine 1 Whole-Body Irradiation 1 Tacrolimus 1 Proton Pump Inhibitors 1 Mycophenolic Acid 1 Hydrocortisone 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Brentuximab Vedotin 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03914885 2021-12-03

Compassionate Use Re-Infusion of ATLCAR.CD30

UNC Lineberger Comprehensive Cancer Center

No longer available

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡